Quintessence debuts first ‘living’ artificial cell for CGT bio-separation

Back to news list

Source: Pharmaceutical Technology

Original: https://www.pharmaceutical-technology.com/news/quintessence-biotech-first-artifi...

Published: Thu, 19 Mar 2026 11:10:38 +0000

Quintessence represents the first "living" artificial cell for biological separation in CGT production. This technology is designed to simplify the biological separation process. At the same time, it reduces production costs in the area of ​​CGT. A "living" artificial cell is used for separation in biotechnological processes. Quintessence technology aims at more efficient separation of biological materials. The separation process is key to the production of CGT therapies.